EL Insider Trading
ESTEE LAUDER COMPANIES INC | Perfumes, Cosmetics & Other Toilet Preparations
Comprehensive Trading Performance Summary
The investment history of corporate insiders at ESTEE LAUDER COMPANIES INC provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Perfumes, Cosmetics & Other Toilet Preparations sector.
Transactions on Chart
Open Full Chart| Filing Date | Trade Date | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|
| 2022-02-10 21:53 | 2022-02-09 | Demsey John | Officer - Group President | OPT+S | $319.68 | 10,027 | $3,205,431 | 6,607 | 0.0% |
| 2022-02-07 20:52 | 2022-02-04 | O'HARE MICHAEL | Officer - EVP-Global Human Resources | OPT+S | $309.88 | 16,389 | $5,078,623 | 0 | 0.0% |
| 2022-02-07 20:51 | 2022-02-04 | Demsey John | Officer - Group President | OPT+S | $314.10 | 23,248 | $7,302,267 | 6,607 | 0.0% |
| 2021-12-13 21:37 | 2021-12-10 | FORESTER LYNN | Director | OPT+S | $361.37 | 1,520 | $549,282 | 14,725 | 0.0% |
| 2021-12-03 21:35 | 2021-12-01 | Lauder William P | Director, Officer, 10% owner - Executive Chairman | OPT+S | $329.18 | 58,720 | $19,329,432 | 0 | 0.0% |
| 2021-11-30 21:19 | 2021-11-30 | PARSONS RICHARD D | Director | SELL | $335.27 | 1,400 | $469,378 | 3,042 | -31.5% |
| 2021-11-19 00:41 | 2021-11-17 | LAL FAMILY PARTNERS LP | 10% owner | SELL | $342.23 | 2,000,000 | $684,460,000 | 0 | -100.0% |
| 2021-11-11 01:51 | 2021-11-10 | TRAVIS TRACEY THOMAS | Officer - EVP & CFO | OPT+S | $344.98 | 47,638 | $16,434,386 | 42,078 | 0.0% |
| 2021-11-08 19:08 | 2021-11-05 | MOSS SARA E | Officer - Vice Chairman | SELL | $345.90 | 2,035 | $703,907 | 0 | -100.0% |
| 2021-11-05 17:59 | 2021-11-04 | Haney Carl P. | Officer - EVP Research Prod & Innovation | SELL | $338.81 | 1,682 | $569,878 | 7,632 | -18.1% |
| 2021-11-04 22:33 | 2021-11-04 | Hertzmark Hudis Jane | Officer - Executive Group President | SELL | $340.06 | 9,043 | $3,075,163 | 39,408 | -18.7% |
| 2021-11-04 20:17 | 2021-11-03 | O'HARE MICHAEL | Officer - EVP-Global Human Resources | SELL | $335.00 | 1,961 | $656,935 | 0 | -100.0% |
| 2021-11-03 23:43 | 2021-11-03 | Haney Carl P. | Officer - EVP-Global R&D | SELL | $336.66 | 1,500 | $504,990 | 9,314 | -13.9% |
| 2021-11-03 23:43 | 2021-11-03 | Demsey John | Officer - Group President | SELL | $335.00 | 6,000 | $2,010,000 | 6,607 | -47.6% |
| 2021-11-03 00:45 | 2021-11-02 | Freda Fabrizio | Director, Officer - President and CEO | OPT+S | $317.04 | 10,432 | $3,307,329 | 75,674 | 0.0% |
| 2021-09-08 01:03 | 2021-09-02 | MOSS SARA E | Officer - Vice Chairman | SELL | $342.56 | 3,451 | $1,182,170 | 0 | -100.0% |
| 2021-09-08 01:03 | 2021-09-03 | O'HARE MICHAEL | Officer - EVP-Global Human Resources | SELL | $343.18 | 2,947 | $1,011,351 | 0 | -100.0% |
| 2021-09-08 01:02 | 2021-09-03 | Freda Fabrizio | Director, Officer - President and CEO | SELL | $342.59 | 14,961 | $5,125,541 | 75,674 | -16.5% |
| 2021-08-26 22:44 | 2021-08-25 | ZINTERHOFER AERIN LAUDER TRUST U/A/D 4/24/00 | 10% owner | SELL | $335.95 | 184,293 | $61,912,920 | 0 | -100.0% |
| 2021-08-23 20:42 | 2021-08-20 | STERNLICHT BARRY S | Director | OPT+S | $329.42 | 4,576 | $1,507,426 | 30,982 | 0.0% |
| 2021-08-23 20:38 | 2021-08-20 | Christianson Wei Sun | Director | OPT+S | $329.33 | 810 | $266,757 | 7,084 | 0.0% |
| 2021-08-23 18:53 | 2021-08-20 | Demsey John | Officer - Group President | SELL | $327.53 | 6,500 | $2,128,955 | 2,019 | -76.3% |
| 2021-07-15 00:19 | 2021-07-14 | TRAVIS TRACEY THOMAS | Officer - EVP & CFO | OPT+S | $325.01 | 53,531 | $17,398,116 | 31,339 | 0.0% |
| 2021-07-02 01:04 | 2021-07-01 | Freda Fabrizio | Director, Officer - President and CEO | OPT+S | $317.45 | 63,516 | $20,163,237 | 75,674 | 0.0% |
| 2021-06-28 23:10 | 2021-06-25 | TRAVIS TRACEY THOMAS | Officer - EVP & CFO | OPT+S | $310.01 | 26,792 | $8,305,788 | 31,339 | 0.0% |
| 2021-06-14 23:14 | 2021-06-11 | ZINTERHOFER AERIN LAUDER TRUST U/A/D 4/24/00 | 10% owner | SELL | $300.53 | 97,971 | $29,442,803 | 184,293 | -34.7% |
| 2021-06-11 22:33 | 2021-06-09 | ZINTERHOFER AERIN LAUDER TRUST U/A/D 4/24/00 | 10% owner | SELL | $298.54 | 222,736 | $66,495,026 | 282,264 | -44.1% |
| 2021-06-11 22:33 | 2021-06-10 | LAUDER JANE | Director | OPT+S | $298.50 | 22,752 | $6,791,497 | 50,783 | 0.0% |
| 2021-06-09 23:54 | 2021-06-08 | ZINTERHOFER AERIN LAUDER TRUST U/A/D 4/24/00 | 10% owner | SELL | $301.46 | 170,000 | $51,248,557 | 505,000 | -25.2% |
| 2021-06-08 18:32 | 2021-06-07 | Hockaday Irvine O Jr | Director | SELL | $302.23 | 2,740 | $828,110 | 0 | -100.0% |
| 2021-06-02 23:06 | 2021-06-01 | Freda Fabrizio | Director, Officer - President and CEO | SELL | $308.00 | 32,209 | $9,920,372 | 75,674 | -29.9% |
| 2021-06-01 18:00 | 2021-05-27 | BRAVO ROSE MARIE | Director | OPT+S | $304.23 | 4,234 | $1,288,110 | 0 | 0.0% |
| 2021-05-11 20:41 | 2021-05-10 | FORESTER LYNN | Director | OPT+S | $303.15 | 880 | $266,772 | 7,696 | 0.0% |
| 2021-05-10 23:13 | 2021-05-07 | PARSONS RICHARD D | Director | OPT+S | $302.36 | 2,329 | $704,196 | 0 | 0.0% |
| 2021-05-10 23:01 | 2021-05-07 | TRAVIS TRACEY THOMAS | Officer - EVP & CFO | OPT+S | $305.01 | 26,792 | $8,171,828 | 31,339 | 0.0% |
| 2021-05-07 21:32 | 2021-05-07 | Demsey John | Officer - Group President | SELL | $299.90 | 1,500 | $449,850 | 8,519 | -15.0% |
| 2021-05-05 23:53 | 2021-05-05 | LAUDER RONALD S | Officer, 10% owner - Chairman, Clinique Labs LLC | SELL | $292.00 | 1,700,000 | $496,400,000 | 0 | -100.0% |
| 2021-05-05 23:21 | 2021-05-04 | O'HARE MICHAEL | Officer - EVP-Global Human Resources | SELL | $294.59 | 2,183 | $643,100 | 0 | -100.0% |
| 2021-05-05 23:20 | 2021-05-04 | Demsey John | Officer - Group President | SELL | $296.02 | 1,000 | $296,020 | 10,019 | -9.1% |
| 2021-05-05 20:27 | 2021-05-04 | BARSHEFSKY CHARLENE | Director | OPT+S | $293.54 | 910 | $267,121 | 43,250 | 0.0% |
| 2021-04-12 23:13 | 2021-04-09 | TRAVIS TRACEY THOMAS | Officer - EVP & CFO | OPT+S | $300.01 | 22,924 | $6,877,429 | 31,339 | 0.0% |
| 2021-04-12 23:12 | 2021-04-09 | MOSS SARA E | Officer - Vice Chairman | OPT+S | $300.00 | 12,000 | $3,600,000 | 0 | 0.0% |
| 2021-03-10 20:46 | 2021-03-09 | TRAVIS TRACEY THOMAS | Officer - EVP & CFO | OPT+S | $285.01 | 22,924 | $6,533,569 | 31,339 | 0.0% |
| 2021-03-09 00:12 | 2021-03-08 | LAL FAMILY PARTNERS LP | 10% owner | SELL | $282.19 | 2,000,000 | $564,380,000 | 0 | -100.0% |
| 2021-03-08 18:55 | 2021-03-05 | BRAVO ROSE MARIE | Director | SELL | $289.52 | 4,000 | $1,158,099 | 0 | -100.0% |
| 2021-03-04 22:00 | 2021-03-02 | LAUDER RONALD S | Officer, 10% owner - Chairman, Clinique Labs LLC | SELL | $290.52 | 78,371 | $22,768,288 | 0 | -100.0% |
| 2021-03-04 02:40 | 2021-03-03 | LAUDER RONALD S | Officer, 10% owner - Chairman, Clinique Labs LLC | SELL | $291.76 | 281,629 | $82,169,063 | 78,371 | -78.2% |
| 2021-03-04 02:38 | 2021-03-03 | LAUDER RONALD S FOUNDATION | 10% owner | SELL | $291.71 | 10,000 | $2,917,130 | 66,971 | -13.0% |
| 2021-03-02 23:16 | 2021-03-01 | PROUVE CEDRIC | Officer - Group President, International | OPT+S | $293.81 | 14,753 | $4,334,580 | 237,519 | 0.0% |
| 2021-02-27 02:03 | 2021-02-24 | PROUVE CEDRIC | Officer - Group President, International | OPT+S | $295.37 | 27,406 | $8,094,924 | 237,519 | 0.0% |
How to Interpret $EL Trades
Not every insider transaction in ESTEE LAUDER COMPANIES INC is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $EL shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.
Data Source & Accuracy for EL
Insider activity data for ESTEE LAUDER COMPANIES INC is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $EL, allowing you to follow the capital of those with the most intimate knowledge of the company.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.